MedTrace Logo

Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3)

NCT06984705 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 144

Last updated 2025-05-29

No results posted yet for this study

Summary

The goal of this study is to evaluate the effectiveness of smallpox vaccination administered before the global eradication of smallpox against currently circulating mpox in the Democratic Republic of the Congo.

The main question it aims to answer is:

Is the smallpox vaccine experience protective against mpox infection ?

Researchers will compare mpox test positive group and negative group to see if the smallpox vaccine can protect against mpox infection.

Participants will

* be included after informed consent,
* respond the survey with structured questionnaire
* and accept skin lesion and blood sampling.

Conditions

  • Mpox (Monkeypox)

Sponsors & Collaborators

  • Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

    collaborator OTHER

  • Osaka Metropolitan University

    lead OTHER

Principal Investigators

  • Natsuko Kaku, PhD · Osaka Metropolitan University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Democratic Republic of the Congo

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06984705 on ClinicalTrials.gov